To confirm the cholangiocyte phenotype of the ECO, we initially performed whole-mount immunofluorescence for SRY-box transcription factor 9, and cytokeratin 7 (KRT7), both expressed uniquely in cholangiocytes within the liver. The gene discussed is SOX9; the disease is endocrine-cerebro-osteodysplasia syndrome.